Hong Kong began vaccination against Wuhan pneumonia three weeks ago, in recent days the cases of infection back down to low double-digit, but yesterday (19) days after the first vaccination more effective BioNTech (Fubetai) death cases, involving a male elderly with a long history of hypertension and other medical conditions, becoming the eighth death cases in Hong Kong after vaccination. Although the Hong Kong government’s expert committee said there was no direct causal relationship between the death and the vaccination, some experts said the public’s confidence in vaccination would inevitably be affected.
According to official data, 304,000 people have received the first dose of vaccine, accounting for about 4% of Hong Kong’s population. Among them, about 210,000 people received the vaccine made by China Kexing and 90,000 people received BioNTech (Fubetai), the latter of which has seen a significant increase in the number of vaccinations, while the vaccination rates after appointments were 84% and 96%, respectively. But yesterday’s deaths involved the higher confidence of Hong Kong people BioNTech, the Secretary for Food and health Chan Siu-chee pointed out this morning in a radio program, the public is more “careful”, some people need to consider whether to vaccinate, and in order to release the public to explain the doubts and considerations, the authorities are compiling the mortality rate of different diseases for public reference, stressing The most important thing is that there is no causal relationship between the case and the vaccine, and call on the public to vaccinate, and stress that they will ensure open and transparent information.
The Hong Kong Government expert adviser Xu Shuchang, chair professor of respiratory Medicine at the Chinese University of Hong Kong, said after attending the same program that the vaccination rate in Hong Kong is low, coupled with the confirmed cases of Wu Peng of unknown origin in Hong Kong is still 20%, I believe that there may not be many countries willing to discuss the issue of clearance with Hong Kong, the current need to first improve the vaccination rate.
The latest case of death after vaccination involves a 66-year-old man suffering from diabetes, hypertension and hyperlipidemia, who was vaccinated with BioNTech at a community vaccination center in the New Territories on the 16th of this month, and was found fainting in his car three days later in the morning, and was sent to the hospital for resuscitation to confirm his death. This is the first case of death after receiving the BioNTech vaccination program since it began 10 days ago. Before that, seven people died after receiving the Kexin vaccine, and the New Crown Vaccine Clinical Event Evaluation Expert Committee concluded that the first seven deaths were not directly causally related to the vaccine.
The latest death will be submitted to the Expert Committee on Vaccine Clinical Event Assessment next week to assess the causal relationship with the vaccine. But Xu Shucheng estimated that the above cases of the deceased have many cardiovascular-related risk factors, does not rule out the possibility of myocardial infarction caused by natural death, but to determine the cause of death autopsy. He pointed out this morning in the radio program, according to the Hospital Authority 2019 data, 14 people over 65 years of age died of cardiovascular disease every day; 7 people died of acute stroke, because some if there are high-risk factors, natural death still exists.
Hong Kong now allows the public to vaccinate the two vaccines are required to play two shots, Xu Shucheng said, vaccination of the first shot and not the second shot, the protection will be insufficient, will be the former work wasted. It is understood that the officials who have earlier received the first injection of Kexing vaccine will receive the second injection next week.
Recent Comments